Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Knowledge Transfer from Cancer Research

International Journal of Cancer to be published by the Deutsches Krebsforschungszentrum from January 2000

No. 05 | 26/01/2000 | by (And)

The International Journal of Cancer is dedicated to publishing and expanding biomedical knowledge about the causes, prevention, detection, and treatment of cancer. Since its foundation in 1966 by the International Union Against Cancer (UICC) in Geneva the journal has operated first from the University of Helsinki, Department of Pathology, Finland, and then from the Swiss Institute for Experimental Cancer Research in Epalinges/Lausanne, Switzerland. Now, the Deutsches Krebsforschungszentrum (German Cancer Research Center) in Heidelberg, Germany, is the third European research institution to assume responsibility for the publication of the journal.

The aim of the International Journal of Cancer, which is published in English, is to present news from the whole scope of international cancer research and to make this information available for a broad readership of scientists and other persons interested in cancer. The journal will continue to be dedicated to this founding mission under the new Editor-in-Chief, Professor Harald zur Hausen, Chairman and Scientific Member of the Management Board of the Deutsches Krebsforschungszentrum. On commission of the UICC, zur Hausen will run the journal for the next five years as of January 1st, 2000. There are plans to expand the journal’s coverage to take account of the emergence of new fields of research.

Expert knowledge on topics related to cancer risk factors and cancer prevention, tumor cell regulation, immunology, and tumor genetics will be provided by four divisional heads of the Deutsches Krebsforschungszentrum. Associate Editors Professor Helmut Bartsch, Professor Norbert Fusenig, Professor Peter Krammer, and Privatdozent Dr. Peter Lichter will support Professor Harald zur Hausen in selecting among the scientific papers submitted.

The publication process will also be coordinated at the Center. With the new year, Leslie Thomas from New York took up her work as Managing Editor in Heidelberg. Thomas, who previously worked for the "Journal of Cell Biology", will be responsible for managing the peer-review process of the manuscripts. In addition, she will be steering the later production phases in coordination with the journal’s New York-based publisher John Wiley & Sons, Inc.

The task of the Deutsches Krebsforschungszentrum in Heidelberg (German Cancer Research Center, DKFZ) is to systematically investigate the mechanisms of cancer development and to identify cancer risk factors. The results of this basic research are expected to lead to new approaches in the prevention, diagnosis and treatment of cancer. The Center is financed to 90 percent by the Federal Ministry of Education and Research and to 10 percent by the State of Baden-Wuerttemberg. It is a member of the Helmholtz Association of National Research Centers (Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V.).

RSS-Feed

Subscribe to our RSS-Feed.

to top
powered by webEdition CMS